Literature DB >> 19264371

Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects.

Jang Yel Shin1, Sei Jin Chang, Young Goo Shin, Kwang-Seok Seo, Choon Hee Chung.   

Abstract

We investigated the associations of gamma-glutamyltransferase (GGT) with visceral obesity, adiponectin and retinol binding protein 4 (RBP4), and insulin resistance (IR) and compared these associations with other liver enzymes in non-diabetes. We enrolled 94 healthy subjects 30-69 years old. Clinical and biochemical metabolic parameters were measured. Adiponectin and RBP4 were determined by ELISA. IR was examined by HOMA-IR. Visceral fat was determined by computed tomography scan. GGT and alanine aminotransferase (ALT) were positively correlated with waist circumference (WC), waist-to-hip ratio (WHR), visceral fat area (VFA), visceral-to-subcutaneous fat area ratio (VSR), HOMA-IR, and RBP4, but was negatively correlated with adiponectin (p<0.05). In multivariate regression, GGT was associated with male sex, HOMA-IR, and RBP4 (R(2)=0.48, p<0.05) and ALT was associated with HOMA-IR (R(2)=0.22, p<0.05). By logistic regression after adjusted for age and sex, the odds ratio (OR) for IR in the highest tertile of sex-specific GGT and ALT were significantly increased compared to those in the lowest [OR (95% CI); 6.90 (2.08-22.82), 3.38 (1.08-10.57), respectively]. However, these relationships after further adjustments for RBP4, adiponectin, VFA, VSR, WHR, WC, TG, and HDL remained significant in only GGT. In conclusions, GGT may be a useful marker of IR in non-diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19264371     DOI: 10.1016/j.diabres.2009.02.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction.

Authors:  Chiara Lazzeri; Serafina Valente; Roberto Tarquini; Marco Chiostri; Claudio Picariello; Gian Franco Gensini
Journal:  Intern Emerg Med       Date:  2010-09-29       Impact factor: 3.397

2.  New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients.

Authors:  Li Wang; Juanjuan Zhang; Bokai Wang; Yuwen Zhang; Jie Hong; Yifei Zhang; Weiqing Wang; Weiqiong Gu
Journal:  Endocrine       Date:  2013-04-03       Impact factor: 3.633

3.  Cross-sectional association between gamma-glutamyl transferase and hyperuricaemia: the China Multi-Ethinic Cohort (CMEC) study.

Authors:  Yanjiao Wang; Fang Xu; Xuehui Zhang; Fei Mi; Ying Qian; Rudan Hong; Wei Zou; Hua Bai; Likun He; Songmei Wang; Jianzhong Yin
Journal:  BMJ Open       Date:  2022-05-30       Impact factor: 3.006

4.  Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study.

Authors:  Ina-Maria Rückert; Margit Heier; Wolfgang Rathmann; Sebastian E Baumeister; Angela Döring; Christa Meisinger
Journal:  PLoS One       Date:  2011-08-05       Impact factor: 3.240

5.  Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.

Authors:  Leon Fisher; Wichat Srikusalanukul; Alexander Fisher; Paul Smith
Journal:  Int J Med Sci       Date:  2015-01-01       Impact factor: 3.738

6.  Abdominal adiposity distribution in diabetic/prediabetic and nondiabetic populations: a meta-analysis.

Authors:  Jane J Lee; S Natasha Beretvas; Jeanne H Freeland-Graves
Journal:  J Obes       Date:  2014-11-26

7.  Non-linear relationship between gamma-glutamyl transferase and type 2 diabetes mellitus risk: secondary analysis of a prospective cohort study.

Authors:  Hao Wang; Lixia Li; Shouyan Zhang
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

8.  Gamma-glutamyl transferase to high-density lipoprotein cholesterol ratio: A valuable predictor of type 2 diabetes mellitus incidence.

Authors:  Wangcheng Xie; Bin Liu; Yansong Tang; Tingsong Yang; Zhenshun Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.